AIM
IBB icon

Acropolis Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Acropolis Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
8,187
-715
-8% -$123K 0.06% 101
2026
Q1 		$1.5M Hold
8,902
– – 0.07% 98
2025
Q4 		$1.5M Sell
8,902
-24
-0.3% -$3.9K 0.07% 93
2025
Q3 		$1.13M Buy
8,926
+1,668
+23% +$228K 0.06% 106
2025
Q2 		$918K Hold
7,258
– – 0.05% 105
2025
Q1 		$928K Sell
7,258
-270
-4% -$36.6K 0.06% 99
2024
Q4 		$995K Sell
7,528
-315
-4% -$44.3K 0.06% 99
2024
Q3 		$1.14M Sell
7,843
-495
-6% -$71.6K 0.07% 95
2024
Q2 		$1.14M Sell
8,338
-147
-2% -$19.6K 0.07% 95
2024
Q1 		$1.16M Sell
8,485
-510
-6% -$69.6K 0.08% 89
2023
Q4 		$1.22M Hold
8,995
– – 0.09% 85
2023
Q3 		$1.1M Sell
8,995
-132
-1% -$16.8K 0.09% 87
2023
Q2 		$1.16M Sell
9,127
-250
-3% -$32.5K 0.09% 84
2023
Q1 		$1.21M Sell
9,377
-93
-1% -$12.2K 0.1% 80
2022
Q4 		$1.24M Sell
9,470
-145
-2% -$18.7K 0.11% 73
2022
Q3 		$1.13M Hold
9,615
– – 0.11% 74
2022
Q2 		$1.13M Sell
9,615
-261
-3% -$31K 0.11% 78
2022
Q1 		$1.29M Sell
9,876
-120
-1% -$15.6K 0.12% 77
2021
Q4 		$1.53M Sell
9,996
-300
-3% -$46.4K 0.14% 64
2021
Q3 		$1.65M Hold
10,296
– – 0.2% 58
2021
Q2 		$1.69M Sell
10,296
-237
-2% -$36.5K 0.16% 56
2021
Q1 		$1.59M Sell
10,533
-34
-0.3% -$5.4K 0.16% 57
2020
Q4 		$1.6M Sell
10,567
-35
-0.3% -$5K 0.18% 49
2020
Q3 		$1.44M Sell
10,602
-83
-0.8% -$11.3K 0.18% 49
2020
Q2 		$1.46M Buy
10,685
+46
+0.4% +$5.86K 0.19% 43
2020
Q1 		$1.15M Sell
10,639
-481
-4% -$55.4K 0.18% 51
2019
Q4 		$1.34M Sell
11,120
-50
-0.4% -$5.58K 0.19% 51
2019
Q3 		$1.11M Sell
11,170
-207
-2% -$21.7K 0.16% 60
2019
Q2 		$1.24M Buy
11,377
+100
+0.9% +$10.6K 0.19% 51
2019
Q1 		$1.26M Sell
11,277
-231
-2% -$25.3K 0.2% 48
2018
Q4 		$1.11M Hold
11,508
– – 0.19% 48
2018
Q3 		$1.4M Sell
11,508
-163
-1% -$19.2K 0.23% 42
2018
Q2 		$1.28M Hold
11,671
– – 0.21% 43
2018
Q1 		$1.25M Sell
11,671
-1,067
-8% -$118K 0.2% 59
2017
Q4 		$1.36M Sell
12,738
-90
-0.7% -$9.62K 0.21% 46
2017
Q3 		$1.43M Sell
12,828
-1,635
-11% -$175K 0.23% 42
2017
Q2 		$1.5M Sell
14,463
-219
-1% -$21.6K 0.25% 45
2017
Q1 		$1.44M Sell
14,682
-450
-3% -$43.1K 0.25% 45
2016
Q4 		$1.34M Sell
15,132
-882
-6% -$80.3K 0.25% 46
2016
Q3 		$1.54M Sell
16,014
-1,017
-6% -$96.8K 0.29% 43
2016
Q2 		$1.46M Sell
17,031
-30
-0.2% -$2.69K 0.28% 44
2016
Q1 		$1.48M Sell
17,061
-1,875
-10% -$168K 0.29% 44
2015
Q4 		$2.14M Sell
18,936
-1,407
-7% -$153K 0.43% 29
2015
Q3 		$2.06M Sell
20,343
-5,451
-21% -$654K 0.42% 28
2015
Q2 		$3.17M Sell
25,794
-1,254
-5% -$150K 0.62% 19
2015
Q1 		$3.1M Sell
27,048
-3,240
-11% -$357K 0.58% 22
2014
Q4 		$3.06M Sell
30,288
-1,620
-5% -$157K 0.59% 24
2014
Q3 		$2.91M Sell
31,908
-1,650
-5% -$145K 0.58% 26
2014
Q2 		$2.88M Sell
33,558
-7,119
-18% -$561K 0.58% 26
2014
Q1 		$3.21M Buy
40,677
+1,626
+4% +$135K 0.66% 23
2013
Q4 		$2.96M Sell
39,051
-4,464
-10% -$317K 0.64% 25
2013
Q3 		$3.04M Sell
43,515
-39
-0.1% -$2.56K 0.64% 25
2013
Q2 		$2.52M Buy
+43,554
New +$2.52M 0.55% 33

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Acropolis Investment Management's IBB Position: Q2 2026 in Review

Acropolis Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 8% in Q2 2026, selling an estimated $123K and leaving 8,187 shares worth $1.56M. The position accounts for 0.06% of the portfolio, ranked #101.

Acropolis Investment Management first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.21M in Q1 2014. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Acropolis Investment Management held 8,187 shares of iShares Biotechnology ETF worth $1.56M as of Q2 2026.
  • Acropolis Investment Management sold 715 iShares Biotechnology ETF shares in Q2 2026, an estimated $123K.
  • iShares Biotechnology ETF made up 0.06% of Acropolis Investment Management's portfolio in Q2 2026, its #101 holding.
  • Acropolis Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Acropolis Investment Management's iShares Biotechnology ETF position peaked at $3.21M in Q1 2014.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.